Initial C-reactive protein level: Discriminating between anti-TNF and anti-IL-17 agents as the first biologic treatment for axial spondyloarthritis?

被引：0
作者：
Goupille, Philippe [1 ]
Wendling, Daniel [2 ]
机构：
[1] Univ Tours, Trousseau Hosp, Rheumatol Dept, CHU Tours,EA 6295, Ave Republ, F-37044 Tours 9, France
[2] Univ Franche Comte, Rheumatol Dept, CHU Besancon, EA 4266, Besancon, France
来源：
JOINT BONE SPINE | 2024年 / 91卷 / 03期
关键词：
Axial spondyloarthritis; Treatment; C-reactive protein; CLINICAL-RESPONSE; DOUBLE-BLIND; ADALIMUMAB; PREDICTORS; EFFICACY; THERAPY; SAFETY;
D O I：
10.1016/j.jbspin.2023.105662
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 22 条
  • [1] Impact of baseline C-reactive protein levels on the response to secukinumab in ankylosing spondylitis: 3-year pooled data from two phase III studies
    Braun, Juergen
    Deodhar, Atul
    Landewe, Robert
    Baraliakos, Xenofon
    Miceli-Richard, Corinne
    Sieper, Joachim
    Quebe-Fehling, Erhard
    Martin, Ruvie
    Porter, Brian
    Gandhi, Kunal K.
    van der Heijde, Desiree
    Gallagher, John
    Maity, Niladri
    Pillai, Neeta
    [J]. RMD OPEN, 2018, 4 (02):
  • [2] Secukinumab in non-radiographic axial spondyloarthritis: subgroup analysis based on key baseline characteristics from a randomized phase III study, PREVENT
    Braun, Jurgen
    Blanco, Ricardo
    Marzo-Ortega, Helena
    Gensler, Lianne S.
    van den Bosch, Filip
    Hall, Stephen
    Kameda, Hideto
    Poddubnyy, Denis
    van de Sande, Marleen
    Wiksten, Anna S.
    Porter, Brian O.
    Shete, Abhijit
    Richards, Hanno B.
    Haemmerle, Sibylle
    Deodhar, Atul
    [J]. ARTHRITIS RESEARCH & THERAPY, 2021, 23 (01)
  • [3] Deodhar A, 2019, CLIN EXP RHEUMATOL, V37, P260
  • [4] Improvement of Signs and Symptoms of Nonradiographic Axial Spondyloarthritis in Patients Treated With Secukinumab: Primary Results of a Randomized, Placebo-Controlled Phase III Study
    Deodhar, Atul
    Blanco, Ricardo
    Dokoupilova, Eva
    Hall, Stephen
    Kameda, Hideto
    Kivitz, Alan J.
    Poddubnyy, Denis
    van de Sande, Marleen
    Wiksten, Anna S.
    Porter, Brian O.
    Richards, Hanno B.
    Haemmerle, Sibylle
    Braun, Juergen
    [J]. ARTHRITIS & RHEUMATOLOGY, 2021, 73 (01) : 110 - 120
  • [5] Ixekizumab for patients with non-radiographic axial spondyloarthritis (COAST-X): a randomised, placebo-controlled trial
    Deodhar, Atul
    van der Heijde, Desiree
    Gensler, Lianne S.
    Kim, Tae-Hwan
    Maksymowych, Walter P.
    Ostergaard, Mikkel
    Poddubnyy, Denis
    Marzo-Ortega, Helena
    Bessette, Louis
    Tomita, Tetsuya
    Leung, Ann
    Hojnik, Maja
    Gallo, Gaia
    Li, Xiaoqi
    Adams, David
    Carlier, Hilde
    Sieper, Joachim
    [J]. LANCET, 2020, 395 (10217) : 53 - 64
  • [6] Factors associated with the retention of secukinumab in patients with axial spondyloarthritis in real-world practice: results from a retrospective study (FORSYA)
    Dougados, Maxime
    Lucas, Julien
    Desfleurs, Emilie
    Claudepierre, Pascal
    Goupille, Philippe
    Ruyssen-Witrand, Adeline
    Saraux, Alain
    Tournadre, Anne
    Wendling, Daniel
    Lukas, Cedric
    [J]. RMD OPEN, 2023, 9 (01):
  • [7] Symptomatic Efficacy of Etanercept and Its Effects on Objective Signs of Inflammation in Early Nonradiographic Axial Spondyloarthritis A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
    Dougados, Maxime
    van der Heijde, Desiree
    Sieper, Joachim
    Braun, Juergen
    Maksymowych, Walter P.
    Citera, Gustavo
    Miceli-Richard, Corinne
    Wei, James Cheng-Chung
    Pedersen, Ron
    Bonin, Randi
    Rahman, Mahboob U.
    Logeart, Isabelle
    Wajdula, Joseph
    Koenig, Andrew S.
    Vlahos, Bonnie
    Alvarez, Daniel
    Bukowski, Jack F.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2014, 66 (08) : 2091 - 2102
  • [8] IMPACT OF BASELINE CRP LEVEL ON SECUKINUMAB (SEC) RETENTION IN AXIAL SPONDYLOARTHRITIS (AXSPA): RESULTS OF THE FRENCH RETROSPECTIVE STUDY FORSYA
    Goupille, P.
    Dougados, M.
    Lardy-Cleaud, A.
    Desfleurs, E.
    Claudepierre, P.
    Ruyssen-Witrand, A.
    Saraux, A.
    Tournadre, A.
    Lukas, C.
    Wendling, D.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 886 - 887
  • [9] Toward a tailored therapeutic prescription for patients with axial spondyloarthritis
    Goupille, Philippe
    Wendling, Daniel
    [J]. JOINT BONE SPINE, 2021, 88 (02)
  • [10] Are the recommendations for the use of anti-TNF drugs during axial spondyloarthritis relevant for non-radiographic forms?
    Goupille, Philippe
    Wendling, Daniel
    [J]. JOINT BONE SPINE, 2020, 87 (05) : 381 - 383
123